%PDF-1.6
%
1 0 obj
<>stream
2021-09-15T18:38:28+05:30
2021-10-19T17:43:39-07:00
2021-10-19T17:43:39-07:00
LaTeX with hyperref package
Acrobat Distiller 10.0.0 (Windows); modified using iText 4.2.0 by 1T3XT
10.1002/cac2.12214
10.1002/(ISSN)2523-3548
3
VoR
10.1002/cac2.12214
application/pdf
Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
uuid:c83ac75f-0665-314e-a470-823959ed7f50
uuid:52810635-ba8d-424d-b1f5-7c1e5f81a9f7
endstream
endobj
4 0 obj
<>stream
x[IsHW0ƄQ+ ejon<DIMsw~?RGgrHY#eAġII~0۫(4